Skip to main content
LeanLife Health Inc. logo

LeanLife Health Inc. — Investor Relations & Filings

Ticker · LNLHF ISIN · US5218551066 LEI · 549300J5XQIZMR9LLR50 CSE Manufacturing
Open in API
Filings indexed 64 across all filing types
Latest filing 2024-12-03 Board/Management Inform…
Country CA Canada
Listing CSE LNLHF

About LeanLife Health Inc.

https://www.leanlifehealth.com/

LeanLife Health Inc. develops and distributes plant-based health products globally, focusing on proprietary, shelf-stable omega-3 fatty acid formulations derived from flaxseeds. These high-concentration omega-3 products serve as nutritional additives for residential and commercial food processing, suitable for incorporation into baked goods, beverages, and processed meats. The formulations are thermally stable and resistant to oxidation, offering a two-year shelf life without refrigeration, which provides a clear advantage for food manufacturing. The company also markets and distributes iron energy drinks, including a retail brand associated with Mike Tyson.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Board/Management Information Classification · 90% confidence The document is a press release announcing the appointment of a new Chief Executive Officer and Director, which falls under announcements of changes in the company’s board or senior management. This matches the Board/Management Information category.
2024-12-03 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is an announcement from LeanLife Health Inc. regarding a cease trade order (CTO) issued by Canadian securities regulatory authorities due to the company's failure to file required financial statements. It mentions the company is working with auditors to complete audited annual financial statements and interim financial statements for various fiscal periods, along with related management discussion and certifications. The document also announces the reappointment of a CFO to help complete these filings. There are no actual financial statements or detailed financial data included in the text; rather, it is an update on the status of regulatory filings and the CTO. The document is relatively short (4902 characters) and serves as a regulatory update rather than a full financial report or filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance updates that do not fit other specific categories.
2023-11-09 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from LeanLife Health Inc. providing an update on a Cease Trade Order (CTO) related to delays in filing audited annual financial statements and interim financial statements. It discusses the ongoing audit, filing delays, and the impact of the CTO on trading. There are no actual financial statements or detailed financial data included in the text. The document is an announcement about the status of filings and regulatory compliance rather than the filings themselves. It fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about filing delays and trading restrictions, not a full financial report or audit report.
2022-12-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from LeanLife Health Inc. providing an update on the status of a Cease Trade Order (CTO) and announcing an extension of warrants. It discusses delays in filing the annual financial statements for the fiscal year ended March 31, 2022, and the first quarter financial statements for the period ended June 30, 2022. The document does not contain the actual financial statements or detailed financial data but rather an update on filing status and regulatory compliance. It also announces a capital-related event (warrant extension). Given the nature of the document as an announcement about filing delays and a capital update, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and update. It is not the actual annual or interim report, nor a detailed capital/financing update report. Confidence is high due to clear identification of filing delays and regulatory status update without substantive financial data.
2022-11-03 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by LeanLife Health Inc. It details a material change event related to a cease trade order issued due to the company's failure to file its audited annual financial statements and first quarter financial statements by the prescribed deadlines. The document includes a news release updating shareholders on the status of the cease trade order and the company's efforts to remedy the filing default. The content is regulatory in nature, reporting a material change and compliance issues rather than providing the actual financial statements or detailed financial analysis. It is not an annual report, interim report, or earnings release, but rather a regulatory filing informing about a material change and regulatory status. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (6721 characters) and content support this classification, as it is not the report itself but a regulatory disclosure about the failure to file required reports.
2022-09-16 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from LeanLife Health Inc. providing an update on the status of a Cease Trade Order (CTO) issued by Canadian securities regulatory authorities due to the company's failure to file its audited annual financial statements and interim financial statements by the prescribed deadlines. The document discusses regulatory actions, filing defaults, and the company's efforts to remedy the situation. It does not contain the actual financial statements or detailed financial data but rather an announcement about regulatory compliance issues and filing status. The document length is 5615 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Regulatory Filings (RNS), as it is a regulatory announcement about filing status and cease trade orders, not the actual financial reports themselves.
2022-09-14 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.